{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:18:23Z","timestamp":1761488303970,"version":"3.44.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.jinf.2009.08.005","type":"journal-article","created":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T04:16:37Z","timestamp":1250741797000},"page":"277-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia"],"prefix":"10.1016","volume":"59","author":[{"given":"Carlos A.","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Agudelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Cata\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres F.","family":"Zuluaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Vesga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jinf.2009.08.005_bib1","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.jinf.2009.08.005_bib2","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1128\/AAC.34.12.2348","article-title":"Comparative efficacy of daptomycin, vancomycin and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination","volume":"34","author":"Cantoni","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2009.08.005_bib3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1128\/AAC.34.6.1227","article-title":"Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users","volume":"34","author":"Small","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2009.08.005_bib4","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1378\/chest.105.3.826","article-title":"Clinical and epidemiologic investigations of nosocomial pulmonary infections caused by methicillin resistant Staphylococcus aureus","volume":"105","author":"Iwahara","year":"1994","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1016\/j.jinf.2009.08.005_bib5","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0924-8579(00)00303-4","article-title":"Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections","volume":"16","author":"Moise","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2009.08.005_bib6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/381202","article-title":"Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility","volume":"38","author":"Howden","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2009.08.005_bib7","series-title":"Program and Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"Generics and generics","author":"Vesga","year":"2005"},{"key":"10.1016\/j.jinf.2009.08.005_bib8","first-page":"189","article-title":"Recommendations for monitoring serum vancomycin concentrations","volume":"14","author":"James","year":"2001","journal-title":"BUMC Proceedings"},{"key":"10.1016\/j.jinf.2009.08.005_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2009.08.005_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2334-6-55","article-title":"Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases","volume":"6","author":"Zuluaga","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2009.08.005_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/j.1552-4604.1986.tb03531.x","article-title":"Generic equivalence: issues and concerns","volume":"26","author":"Lamy","year":"1986","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jinf.2009.08.005_bib12","first-page":"856","article-title":"Understanding the scientific issues embedded in the generic drug approval process","volume":"41","author":"Welage","year":"2001","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.jinf.2009.08.005_bib13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/AAC.00700-07","article-title":"Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"52","author":"Kim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"3 Suppl","key":"10.1016\/j.jinf.2009.08.005_bib14","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1093\/clinids\/3.Supplement_2.S236","article-title":"Vancomycin therapy in severe staphylococcal infections","author":"Kirby","year":"1981","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jinf.2009.08.005_bib15","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42","author":"Levine","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445309002229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445309002229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:12:31Z","timestamp":1759007551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445309002229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0163445309002229"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2009.08.005","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2009.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}